Hadeel N. Sahar, MBBCH
Department of Hospital Medicine, Division of Internal Medicine
Present Title & Affiliation
Primary Appointment
Assistant Professor, Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Assistant Professor, Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2002 | Al Nahrain University College of Medicine, Baghdad, IQ, Doctor in Medicine, MBChB |
Postgraduate Training
| 2020-2021 | Onco- Hospital Fellowship, University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2017-2020 | Clinical Residency, Internal Medicine, Wayne State University/Detroit Medical Center, Detroit, Michigan |
| 2009-2012 | Clinical Fellowship, Medical Oncology Fellowship, King Hussein Cancer Center (KHCC), Amman |
| 2005-2009 | Clinical Residency, Internal Medicine Residency, Jordan Hospital, Amman |
| 2002-2004 | Internship, Al-kadhimiya Teaching Hospital, Baghdad |
Licenses & Certifications
| 2025 | ACLS |
| 2025 | BLS |
| 2024 | DEA |
| 2021 | Texas Full Medical License |
| 2020 | ABIM |
| 2013 | Jordan Board in Medical Oncology |
| 2010 | Arab Board in Internal Medicine |
| 2009 | Jordan Board in Internal Medicine |
Experience & Service
Faculty Academic Appointments
Instructor, Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2021 - 2023
Administrative Appointments/Responsibilities
IDC Chair, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2025 - Present
Other Professional Positions
Poster Judge, ACP Meeting, Houston, TX, 2024
Observership GI Medical Oncology Clinic, Karmanos Weisberg Cancer Treatment Center, Farmington Hills, MI, 2017 - 2017
Volunteer Clinical Assistant, Madison Heights Urgent care & Pediatrics, Madison Heights, MI, 2017 - 2017
Volunteer Research Assistant, Wayne State University/Detroit Medical Center, Detroit, MI, 2017 - 2017
Observership at the GMAP (General Medicine and Pediatrics) clinic, Wayne State University/Detroit Medical Center, Detroit, MI, 2016
Observership hematology department, Henry Ford Hospital, Detroit, MI, 2016
Observership, Heart and Vascular Consultants, Detroit, MI, 2016 - 2016
Specialist Physician, NMC Specialty Hospital Dubai, UAE, Dubai, 2013 - 2014
Specialist Physician, KHCC Amman, Jordan, 2012 - 2013
GI and breast Medical Oncology, H. Lee Moffitt Cancer Center, Tampa, FL, 2012 - 2012
Specialist Physician, KHCC Amman, Jordan, 2009 - 2009
Extramural Institutional Committee Activities
Reviewing any new or revised patient care forms that contain patient health information that may be placed into the medical record in accordance with legal or accreditation requirements. The IDC oversees the process of ongoing medical record review, IDC Chair, The University of Texas MD Anderson Cancer Center, 2025 - Present
Member, Cancer Network, The University of Texas MD Anderson Cancer Center
Member, MRC, The University of Texas MD Anderson Cancer Center
Honors & Awards
| 2019 | First place winner, ACP Michigan Chapter for Clinical Vignette, ACP Michigan Chapter |
| 2002 - 2024 | Best research in general surgery, Al-Nahrain University College of Medicine |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2026. CBC, blood smear and iron study interpretaions. Invited. APRN educational series. Houston, Texas, US.
Regional Presentations
- 2024. 2024 Internal Medicine Research Retreat & Poster Session. Conference. 2024 Internal Medicine Research Retreat & Poster Session, US.
- 2022. Immune Checkpoint Inhibitor (ICI). Conference. Immune Checkpoint Inhibitor (ICI), US.
National Presentations
- 2020. Treatment of Venous Thromboembolism in Cancer Patients. Conference. The University of Texas MD Anderson Cancer Center, US.
International Presentations
- 2011. Presented a case of Metastatic Breast Cancer (TNBC. Conference. Presented a case of Metastatic Breast Cancer (TNBC, US.
- 2008. Presented a case of Rhinocerebral Mucormycosis post Liver Transplant Amman. Conference. Presented a case of Rhinocerebral Mucormycosis post Liver Transplant Amman, JO.
- 2008. Primary Diffuse B cell lymphoma of the bone Amman. Conference. Primary Diffuse B cell lymphoma of the bone Amman, JO.
- 2008. Presented a case of Panhypopituitarism associated with antiphospholipid syndrome Amman. Conference. Presented a case of Panhypopituitarism associated with antiphospholipid syndrome Amman, US.
Selected Publications
Peer-Reviewed Articles
- Brito-Dellan, N, Franco Vega, M, Ruiz, JI, Lu, M, Sahar, HN, Rajapakse, P, Lin, HY, Peterson, CB, Leal Alviarez, DJ, Altay, H, Tomy, S, Manzano, JM. Optimizing inpatient care for lung cancer patients with immune checkpoint inhibitor-related pneumonitis using a clinical care pathway algorithm. Supportive Care in Cancer 32(10), 2024. e-Pub 2024. PMID: 39283351.
- Brito-Dellan N, Franco-Vega M, Sahar HN, Ruiz J, Lu M, Rajapakse P, Lin H, Peterson C, Leal-Alviarez D, Altay H, Tomy S, Manzano J. Optimizing inpatient care for lung cancer patients with immune checkpoint inhibitor-related pneumonitis using a clinical care pathway algorithm. Supportive Care in Cancer, 2024. e-Pub 2024.
- Manzano JM, Sahar H, Aldrich J, Lu M, Shoukier M, Peterson CB, Dickson K, Koom-Dadzie K, Kheder E, Franco Vega MC, Mohammed A, Muthu M, Simbaqueba C, Senechalle MS, Brito-Dellan N. Treatment patterns and outcomes of high-grade immune checkpoint inhibitor-related pneumonitis in an oncology hospitalist service. Supportive Care in Cancer 32(3):160, 2024. e-Pub 2024. PMID: 38366007.
Abstracts
- Pillai Balachandran A, Sadiq N, Chua R, Tijani A, Tierce H, Simbaqueba C, Agu A, Franco-Vega M, Phyu E, Odaro O, Sahar HN, Mohammed A, Phan O, Brito-Dellan N, Manzano J. Risk factors of developing multisystem immunotherapy-related adverse events among patients with breast cancer treated with immune checkpoint inhibitors, 2024.
- Thosani, Sonali, Garmi, Perta, Kikani, Nupur, Best, Conor, Khan, Sonya, Lavis, Victor, Brady, Veronica, Castellanos, Luz, Mehta, Paras, Taylor, Jolyn, Raty, Sally, Sahar HN, Agu, Ann, Fletcher, Otitola, Rivera, Zandra, Horng, Michelle, Bruno, Jeff, Popovich, Shannon, Crowder, Vivian, Varghese, Sigi, Wynn, Tina, Hughes, Cheryl, Palma, Denise. Sweet Success: Implementation of an institution-wide glycemic management initiative, 2024.
- Manzano JG, MD, MPH, FACP, Leal Alviarez DJ, MD, Lu M, PharmD, Franco-Vega M, MD, Sahar H, MD, Ruiz JI, MD, Altay H, MD, Tomy S, NP, Rajapakse P, MD, Brito-Dellan N, MD. Enhancing the Care of Patients with Immune Checkpoint Inhibitor-Related Pneumonitis Through The Development and Implementation Of A Clinical Pathway, 2023. e-Pub 2023.
- Manzano JM, MD, MPH, FACP, Franco-Vega MC, MD, Ruiz JI, MD, Lu M, PharmD, Sahar HN, MD, Alviarez DL, MD, Tomy S, NP, Altay H, Rajapakse P, Lin HY, Brito-Dellan N. Improving the care of patients with lung cancer hospitalized with immune checkpoint inhibitor-related pneumonitis: Implementation of a clinical pathway algorithm, 2023. e-Pub 2023.
- Hadeel, Sahar, MD. Administration of in hospital Chemotherapy to Overcome Acute Right Ventricular (RV) Dysfunction Secondary to a Mass Effect, 2023. e-Pub 2023.
- Manzano JM, MD, MPH, FACP, Franco-Vega MC, MD, Ruiz JI, MD, Lu M, PharmD, Sahar HN, MD, Alviarez DL, MD, Tomy S, NP, Altay H, Rajapakse P, Lin HY, Brito-Dellan N. Improving the care of patients with lung cancer hospitalized with immune checkpoint inhibitor-related pneumonitis: Implementation of a clinical pathway algorithm. JCO, 2023. e-Pub 2023.
- Manzano JG, MD, MPH, FACP, Leal Alviarez DJ, MD, Lu M, PharmD, Franco-Vega M, MD, Sahar H, MD||, Ruiz JI, MD, Altay H, MD, Tomy S, NP, Rajapakse P, MD, Brito-Dellan N, MD. ENHANCING THE CARE OF PATIENTS WITH IMMUNE CHECKPOINT INHIBITOR-RELATED PNEUMONITIS THROUGH THE DEVELOPMENT AND IMPLEMENTATION OF A CLINICAL PATHWAY, 2022. e-Pub 2022.
- Sahar HN, MD, Aldrich J, MD, Peterson C, PhD, Brito-Dellan N, MD, Lu M, PharmD, Shoukier M, MD, Dickson K, MD, Koom-Dadzie K, MD, Kheder E, MD, Franco-Vega M, MD, Mohammed A, MD, Muthu M, DO, Simbaqueba C, MD, Sibille M, MD, Manzano J, MD, MPH. Immune checkpoint inhibitor (ICI)-related pneumonitis among patients with lung cancer admitted to an Oncology Hospitalist Service: Treatment patterns and hospitalization outcomes, 2022. e-Pub 2022.
- Sahar HN, MD, Aldrich J, MD, Peterson C, PhD, Brito-Dellan N, MD, Lu M, PharmD, Shoukier M, MD, Dickson K, MD, Koom-Dadzie K, MD, Kheder E, MD, Franco-Vega M, MD, Mohammed A, MD, Muthu M, DO, Simbaqueba C, MD, Sibille M, MD, Manzano J, MD, MPH. Immune checkpoint inhibitor (ICI)-related pneumonitis among patients with lung cancer admitted to an Oncology Hospitalist Service: Treatment patterns and hospitalization outcomes. Journal of Clinical Oncology 39(15):e21054, 2021. e-Pub 2021.
- Hadeel Sahar MD, Nada Al Masalmeh MD, Sushma Tatineni MD, Mitry M, MD, Asif Alavi MD. Thrombotic Microangiopathy (TMA) Secondary to Tyrosine Kinase Inhibitor (Cabozantinib) A case Report, 2019. e-Pub 2019.
- Sandhu AS, MBBS, Sahar HN, MD, Mohsin SU, MPH, MD, Ali Y, MD, Mathekela T, MBBS, MBBS SD, Aman Ajmeri MD, Levine D, MD. Medical Student Evaluation and Reflection of CBC Ordering to Teach High Value Care (HVC), 2017. e-Pub 2017.
- Sahar H, MD, Bilbisi M, MD, FIDSA. Antibiogram and Susceptibility patterns of antibacterial and antifungal at Jordan Hospital during year 2005, 2005. e-Pub 2005.
- Sahar HN. Long-term Survival Outcomes in Advanced Gastrointestinal Malignancies Following Percutaneous Transhepatic Biliary Drainage: Impact of Hepatic Tumor Volume on Subsequent Chemotherapy Delivery. Research retreat.
Patient Reviews
CV information above last modified August 08, 2026